article thumbnail

FDA advisers recommend Pfizer, Moderna COVID-19 vaccines for youngest children

Healthcare Dive

Independent experts unanimously supported use of both shots in children aged 6 months to 5 years old, clearing the way for an FDA decision.

article thumbnail

Pfizer, BioNTech begin process of asking FDA for COVID-19 vaccine clearance in young kids

Healthcare Dive

The companies said the FDA, in an unusual step, requested they submit the clinical trial data they currently have while testing of a third dose in children under 5.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA clears Novavax's COVID-19 vaccine as 4th option in US

Healthcare Dive

The regulator’s decision comes more than a year after the main part of the principal trial was completed, raising questions about the shot’s effectiveness against omicron.

article thumbnail

US health officials propose annual COVID-19 vaccination for most Americans

Modern Healthcare

The FDA's simplified approach aims to make COVID-19 vaccinations more like the annual flu shot.

article thumbnail

FDA FHIR Pilot Automates Adverse Events Reporting and Validation with Cedars-Sinai and the VA Through eHealth Exchange

Healthcare IT Today

The following is a guest article by Jay Nakashima, President at eHealth Exchange An FDA project aims to make it as easy as possible for clinicians to report adverse drug events and share important clinical data with public health agencies to investigate the event.

FDA 121
article thumbnail

FDA delays review of Pfizer's COVID-19 vaccine for young children in surprise shift

Healthcare Dive

The agency pushed back plans to expedite review of the shot in children under 5, seeking more data on a third dose. An advisory meeting scheduled for next week has been postponed as a result.

article thumbnail

FDA authorizes Pfizer, Moderna COVID-19 vaccines for young children

Healthcare Dive

The much-anticipated decision follows two days after a panel of independent experts unanimously recommended expanding the shots’ use. A CDC panel is meeting Friday and Saturday to develop specific recommendations.